It’s been three months since Lilly launched its obesity pill. Most people are taking Novo’s pill instead.
The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet.
The Source
TWSJ
Business
Barratt Redrow Posts Pretax Profit Increase, Launches $517 million Buyback Program
TWSJ·1h ago·3 min read
Business
How UAW’s Bold Leader Got Caught in New Wave of Union Infighting
TWSJ·1d ago·3 min read
Business
Auto & Transport Roundup: Market Talk
TWSJ·1d ago·3 min read
Tech
Meta Is Flooding the Market With Smartglasses. Privacy Advocates Are Up in Arms.
TWSJ·1d ago·3 min read
Related
On this beat
Health
‘Sully,’ ‘Miracle on the Hudson’ Pilot, Announces Alzheimer’s Diagnosis
TNYT·10h ago·3 min read
Health
CDC looking into several items potentially linked to cyclospora parasite
CBS NEWS·9h ago·3 min read
Health
Cyclospora outbreak leaves consumers guessing which foods are safe
CBS NEWS·8h ago·3 min read
Health
Michigan state health officials are narrowing in on lettuce as a possible culprit in the rapidly expanding explosive-diarrhea outbreak
TWSJ·5h ago·3 min read